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Background: Rose-scented geranium (Pelargonium graveolens L’Hér.), which is used in traditional Tunisian folk
medicine for the treatment of hyperglycaemia, is widely known as one of the medicinal herbs with the highest
antioxidant activity. The present paper is conducted to test the hypoglycemic and antioxidative activities of the leaf
essential oil of P. graveolens.
Methods: The essential oil P. graveolens was administered daily and orally to the rats at two doses of 75 mg/kg and
150 mg/kg body weight (b.w.) for 30 days. The chemical composition of P. graveolens essential oil, body weight,
serum glucose, hepatic glycogen, thiobarbituric acid-reactive substances (TBARS), the components of hepatic, and
renal and serum antioxidant systems were evaluated. The hypoglycemic effect of rose-scented geranium was
compared to that of the known anti-diabetic drug glibenclamide (600 μg/kg b.w.).
Results: After the administration of two doses of essential oil of Pelargonium graveolens L’Hér. together with
glibenclamide which is known by its antidiabetic activities and used as reference (600 μg/kg b.w.), for four weeks,
the serum glucose significantly decreased and antioxidant perturbations were restored. The hypoglycemic effect of
P. graveolens at the dose of 150 mg/kg b.w. was significantly (p< 0.05) more effective than that of glibenclamide.
It is through the histological findings in hepatic and renal tissues of diabetic rats that these beneficial effects of
geranium oils were confirmed.
Conclusions: It suggests that administration of essential oil of P. graveolens may be helpful in the prevention of
diabetic complications associated with oxidative stress. Our results, therefore, suggest that the rose-scented
geranium could be used as a safe alternative antihyperglycemic drug for diabetic patients.
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An overview of the diabetes mellitus (DM) prevalence in
Tunisia shows that it corresponds to 9.3–11.0% (be-
tween 2010 and 2030), which is in accordance with the
percentage observed in other countries. The world
prevalence of diabetes among adults (aged 20–79 years)
is 6.4%, corresponding to 285 million, in 2010, and will
be estimated by 7.7%, equivalent to 439 million, by 2030.
In fact, it is one of the most common chronic diseases
in nearly all countries, and continues to increase in* Correspondence: inesfeki@yahoo.fr
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reproduction in any medium, provided the ornumber and significance due to the changing lifestyles
that lead to the reduction of physical activity and in-
crease of obesity [1].
Numerous studies have demonstrated that oxidative
stress, mediated mainly by hyperglycemia-induced gener-
ation of free radicals, contributes to the development and
progression of diabetes and its complications [2-4]. The
abnormally high level of free radicals leads to membrane
damage because of membrane lipids peroxidation, protein
glycation and the simultaneous decline of antioxidant
defense mechanisms [4,5]. Nowadays, although the major
agents used for diabetes treatment are synthetic drugs
and insulin, they usually come with considerable side
effects, such as hypoglycemia, drug-resistance, dropsy,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Chemical composition of leaf essential oil of
Pelargonium graveolens L’Hér
N° Composant RT KIa %
1 α-pinene 8.870 930 0.66
2 β-myrcene 10.633 997 0.18
3 phellandrene 10.010 1007 0.09
4 β-phellandrene 11.766 1023 0.21
5 cis-ocimene 12.063 1030 0.16
6 β-ocimene 12.378 1037 0.13
7 linalool l 14.003 1073 3.80
8 rose oxide-trans 14.772 1079 0.54
9 l-menthone 15.908 1141 4.13
10 3-p-menthanol 16.418 1186 0.14
11 α-terpineol 16.646 1197 0.24
12 β-citronellol 17.894 1237 16.24
13 z-citral 18.106 1244 0.71
14 nerol 18.495 1259 3.08
15 geraniol 18.706 1266 15.30
16 e-citral 18.981 1277 0.84
17 citronellyl formate 19.113 1282 7.39
18 geraniol formate 19.834 1309 6.47
19 propanoic acid 21.087 1357 0.39
20 lavandulyl acetate 21.893 1388 0.76
21 β-bourbonene 22.014 1393 1.01
22 trans-caryophyllene 22.912 1427 1.63
23 β-cubebene 23.129 1434 0.64
24 citronellyl propionate 23.393 1444 0.14
25 azulene 23.473 1449 0.40
26 α-cubebene 23.662 1458 0.96
27 α-humulene 23.759 1460 0.51
28 aromadendrene 23.942 1467 0.68
29 germacrene-d 24.457 1486 2.87
30 β-selinene 24.577 1492 0.17
31 β-cuvebene 24.709 1496 0.32
32 ledene 24.806 1500 3.10
33 α-muurolene 24.880 1504 0.18
34 elemol 25.029 1510 0.40
35 α-amorphene 25.229 1519 0.29
36 δ-cadinene 25.447 1528 1.36
37 epizonaren 25.504 1530 0.24
38 α-gurjunene 25.790 1545 0.55
39 α-agarofuran 26.030 1553 0.57
40 neryl acetate 26.236 1563 1.06
41 phenylethyl tiglate 26.894 1591 2.07
42 δ-selinene 27.816 1631 8.69
43 agarospirol 28.090 1643 0.46
44 isoledene 28.474 1660 1.18
45 propanoate 28.657 1667 0.43
46 geranyl tiglate 29.475 1703 3.05
Table 1 Chemical composition of leaf essential oil of
Pelargonium graveolens L’Hér (Continued)







a KI, retention index (Kovalts) relative to n-alkanes (C9–C26) on a polar DB-5
MS column.
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folk medicines have proven to be efficient for the treat-
ment of diabetes with less tolerability and side effects,
there is an increasing trend towards searching for more
natural antidiabetic agents.
Rose-scented geranium is an important aromatic plant
that grows in temperate areas of the world [7] including
those in Tunisia. Geranium oil has a fine rosy odor with
pronounced fruity minty undertone and a rich long-
lasting sweet-rosy dryout [8]. As the cost of its highly
valued essential oil, which is used in soaps, perfumery,
and cosmetic industries, is increasing in international
market, attempts were made to promote its cultivation
by employing various agrotechnologies [9].
The essential oil of P. graveolens has been used for
many years in traditional medicine as antiasthmatic,
antiallergic, antioxidant, antidiarrhoeic, antihepatotoxic,
diuretic, tonic, haemostatic, stomachic and diabetic
[10-14].
It is worthwhile to note that no detailed studies have
been carried out on the efficiency of Pelargonium grave-
olens in the modulation of oxidative stress pertaining to
DM in experimental animals. Hence, the present study
undertakes the investigation of possible hypoglycemic
and antioxidant effects of Pelargonium graveolens leaves
in alloxan-induced diabetic rats. Indeed, the essential oil
of rose-scented geranium leaves was prepared and their
antioxidant activities as well as their hypoglycemic
effects were studied.
Results
Chemical constitution of leaf essential oil
The hydrodistillation of the leaves of P. graveolens gener-
ated pale yellow coloured oil (yield of 0.19%, v/w). Upon
GC/MS analysis, the essential oil was found to contain 47
constituents, 96.23% of which were identified (Table 1).
All constituents were eluted between 8 and 31 min. The
volatile oil contained 67.39% monoterpenoids, 25.4% ses-
quiterpenoids, and 3.44 other compounds. The major
components were β-citronellol (16.24%) followed by gera-
niol (15.30%), δ-selinene (8.69%), citronellyl formate
Table 2 Growth Performance of the experimental Rats*
Groups Initial body wt (g) Final body wt (g)
Control 230.16 ± 5.55 a 318.24 ± 9.12 a
Diabetic 225.87 ± 7.94 a 255.39 ± 11.89 b
Glibenclamide (600 μg/kg b.w.) 227.97 ± 6.20 a 277.17 ± 10.23 c
EO 1 (75 mg/kg b.w.) 228.22 ± 6.32 a 280.09 ± 7.66 c
EO 2 (150 mg/kg b.w.) 230.11 ± 5.96 a 301.83 ± 10.54 d
abcd The means in the row not sharing a common letter are significantly
different among groups (p< 0.05).
* Values are expressed as means ± S.E. (n = 8).
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linalool-l (3.8%). Twenty nine components of the oil
amounted to<1%.
Body weight
Table 2 shows the body weight in normal and experi-
mental animals in each group. Indeed, the injection of
alloxan (150 mg/kg) reduced the body weight of diabetic
rats compared with controls. The mean body weight ofFigure 1 Effects of leaf essential oil (EO1 and EO2) and glibenclamide
alloxan-induced diabetic male wistar rats for 30 days. Values are expre
letter are significantly different among groups (p< 0.05).diabetic rats showed a decrease by 19.74% compared
with normal animals. The body weight of diabetic rats
treated with essential oil significantly increased as com-
pared with non-treated diabetic animals.
Serum glucose and hepatic glycogen concentration
The serum glucose levels of diabetic rats were signifi-
cantly higher compared with those of the control group
(p< 0.05) (Figure 1). After the administration of the leaf
essential oil of P. graveolens, a significant decrease in
blood glucose was observed compared with that of the
diabetic group (p< 0.05) (Figure 2). Moreover, rats re-
ceiving essential oil at 150 mg/kg b.w. illustrated a sig-
nificantly pronounced antidiabetic effect compared with
those receiving these compounds at 75 mg/kg b.w. How-
ever, the hepatic glycogen levels showed a significant de-
crease by 86.56% in diabetic rats compared with those in
the controls (Figure 1). Furthermore, all of the groups re-
ceiving the two doses of essential oil of P. graveolens
depicted a significant increase in glycogen levels comparedon serum glucose levels and liver glycogen levels in normal and
ssed as means ± S.E. (n = 8).abcd The means not sharing a common
Figure 2 Effects of leaf essential oil (EO1 and EO2) on blood glucose levels in normal and alloxan-induced diabetic male wistar rats for
30 days. Values are expressed as means ± S.E. (n = 8). Values differ significantly at p< 0.05.
Figure 3 Effects of leaf essential oil (EO1 and EO2) and Glibenclamide on hepatic SOD, CAT, GPX activities and TBARS of diabetic male
wistar rats for 30 days. Values are expressed as means ± S.E. (n = 8). abcd The means not sharing a common letter are significantly different
among groups (p< 0.05).
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The rats receiving essential oil at 150 mg/kg b.w. showed
the significantly highest levels of hepatic glycogen concen-
tration (p< 0.05).
Hepatic function, diabetes and P. graveolens preparations
This study has demonstrated a decrease in the SOD
(superoxide dismutase), CAT (catalase) and GPX (gluta-
thione peroxidase) activities in hepatic tissues of diabetic
rats together with an increase in plasma TBARS levels
(Figure 3). In diabetic rats treated with two doses of es-
sential oil, a clear protective effect was observed in hep-
atic function and metabolism. In fact, the administration
of glibenclamide inhibited all changes caused by alloxan-
induced diabetes. This positive effect of the essential oil
was confirmed by histological findings (Figure 4). As
shown in Figure 4B, vacuolated hepatocytes with the nu-
cleus being pushed to the periphery and fatty cyst were
observed in diabetic rats. This structure is different com-
pared with the livers of normal control rats. However,
the essential oil administration to diabetic rats reduced
the appearance of fat cells in liver (Figure 4D).
Renal function, diabetes and P. graveolens preparations
In diabetic rats, a decrease in the SOD, CAT and GPX
activities by 43.8, 35.7 and 42.12%, respectively, inA
C
Figure 4 (A) Normal rat liver. (B) Diabetic rat liver: sinusoidal congestion
with Glibeclemide and (D) Diabetic rat treated with essential oil (150 mg/kkidneys was shown at the end of the experiment, More-
over, a significant increase of TBARS in kidneys by
37.39% was obtained in alloxan-treated rats (Figure 5).
However, after the essential oil administration, a positive
action from nephropathy was clearly observed. In fact
the renal SOD, CAT and GPX antioxidant activities
increased after the administration of essential oil at
150 mg/kg b.w. Furthermore, the P. graveolens oils
decreased lipid peroxidation content. Moreover, a nor-
mal histological structure was observed (Figure 6A).
This positive effect of these fractions was confirmed by
histological findings. As shown in Figure 6B, although
fatty infiltration was found in the kidneys of diabetic
rats, the structure of the glomeruli remained intact in
the kidneys of the rats treated with essential oil
(Figure 6C, Figure 6D), which is very near to the control
rat kidney histological organisation.
Discussion
Diabetes mellitus, a leading metabolic disorder world-
wide, is characterized by hyperglycemia associated with
impairment in insulin secretion and/or insulin action as
well as alteration in intermediary metabolism of carbohy-
drate, protein and lipids. Reactive oxygen species play a
relevant role in the etiology and pathogenesis of diabetes
mellitus and its complications. Lipid peroxide mediatedB
D
and fatty degeneration in the form of fat lake. (C) Diabetic rat treated
g): a positive effect was observed (H&E 100×).
Figure 5 Effects of leaf essential oil (EO1 and EO2) and Glibenclamide on SOD, CAT, GPX activities and TBARS in kidney of diabetic
male wistar rats for 30 days. Values are expressed as means ± S.E. (n = 8). abcd The means not sharing a common letter are significantly different
among groups (p< 0.05).
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and non-insulin-dependent diabetes mellitus [15]. As a
strategy to counteract the negative effect of oxidative
stress, antioxidant-based therapy is promising to minimize
the complications in diabetes mellitus. The present study
was undertaken to evaluate the hypoglycemic and antioxi-
dant status of leaf essential oil of P. graveolens on alloxan
induced diabetes. To the best of our knowledge, this is the
first report of hypoglycemic activity of this plant. Our
results have proved that the leaf essential oil at two differ-
ent doses, 75 and 150 mg/kg b.w., had significant
hypoglycemic and antioxidant effects comparable to those
of glibenclamide. It has been reported that glibenclamide
produces the hypoglycemic effect by stimulating insulin se-
cretion from β cells of pancreatic islets [16,17]. In the
present study, the oral administration of the essential oil of
P. graveolens brought about significant hypoglycemic
effects in alloxan-induced diabetic rats, mainly at
150 mg/kg b.w. The eventual mechanism responsible for
the hypoglycemic effect of this plant may result from apotentiation of glucose-induced insulin release or
increased peripheral uptake of glucose [18]. In fact, the
hepatic glycogen levels in diabetic rats receiving essential
oil were significantly higher than those of the normal as
well as diabetic rats. The hypoglycemic effect of P. graveo-
lens essential oil extract is probably related to its content
of several bioactive antidiabetic principles. In addition,
the antidiabetic effect of monoterpenes which were the
major compounds identified in Satureja khozestanica es-
sential oil, was previously demonstrated by Tavafi et al.
[16].
Several studies have illustrated the increased lipid per-
oxidation in clinical and experimental diabetes. It has
been established that diabetes leads to increased produc-
tion of oxygen free radicals [19,20] which exert their
cytotoxic effect by causing lipid peroxidation, resulting
in the formation of TBARS. In our study, alloxan-
induced diabetic rats showed a significant rise in liver
and kidney TBARS levels. The treatment of diabetic rats
with the leaf essential oil of P. graveolens has confirmed
A B
C D
Figure 6 (A) Normal rat kidney. (B) Diabetic treated rat kidney: tubular epithelial damage messangial capillary proliferation and fatty infiltration.
(C) Diabetic rat treated with Glibeclemide and (D) Diabetic rat treated with essential oil (150 mg/kg): a positive effect was observed (H&E 100×).
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These data suggest that rats treated with P. graveolens
oil are less susceptible to peroxidative damage under the
challenge of oxidative stress such as diabetes.
It has also been reported that oxidative stress may
constitute the key and common event in the pathogen-
esis of different diabetic complications [21]. This stress
results from an imbalance between the production of
free radicals and the effectiveness of the antioxidant de-
fence system [22]. Dietary monoterpenes appear to have
physiological antioxidant properties, which quench re-
active oxygen and nitrogen species, thereby potentially
contributing against the pathogenesis of diabetic com-
plications [16,23]. In the present study, we have
observed decreased activities of antioxidant enzymes
CAT, SOD and GPX in the liver and kidneys of diabetic
group. Our results are in harmony with those obtained
in previous studies, which suggests that hyperglycemia
induces a depletion of the antioxidant system due to
the increased lipid peroxidation and formation of free
radicals [24-26]. The treatment of alloxan-induced dia-
betic rats with the leaf essential oil of rose-scented ge-
ranium was confirmed to increase the SOD, CAT and
GPX activities. The increase may be due to the activa-
tion of enzymes by P. graveolens essential oil, resulting
in a lower superoxide anion level. Besides, the higherCAT, SOD and GPX activity could lead to a reduced
reactive oxygen species level in P. graveolens oil supple-
mented group. These results suggest that P. graveolens
oils reduce oxidative stress by preventing the gener-
ation of free radicals and, thus inhibiting the develop-
ment of diabetes. The reduced oxidative stress and lipid
peroxidation observed in the geranium essential oils
treated animals may be attributed to the important role
of the essential oil as antioxidants. This power may be
attributed to their ability to decompose free radicals by
quenching reactive oxygen species and trapping radicals
before reaching their cellular targets [27]. The antioxi-
dant activity of geranium essential oil could also be
assigned to the presence of monoterpenes. The geraniol
and β-citronellol were the major monoterpenes
detected in the chemical composition of geranium oils
(Table 1). Indeed, Singh et al. [28] assessed the antioxi-
dant and radical scavenging activity of two major
monoterpenes (citronellal and β-citronellol) present in
the essential oil of Artemisia scoparia. Moreover, the
measured antioxidant activities could be due to the
synergistic effects of two or more compounds present
in the oils. In this context, Lu and Foo and Nivitabishe-
kam et al. [29,30] reported that most natural antioxida-
tive compounds often work synergistically with each
other to produce a broad spectrum of antioxidative
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against free radicals.
In Conclusion, the present study clearly demonstrates
that the essential oil of Pelargonium graveolens not only
exhibit a pronounced hypoglycemic effect but also re-
duce the lipid peroxidation process as well as enhance
the antioxidant defence system. For further studies, iso-
lation and investigation of the chemical constituent of
the essential oil of P. graveolens responsible for the
hypoglycemic effect should be undertaken in order to
confirm and clarify the mechanism behind this activity.
Materials and methods
Chemicals and reagents
Alloxan, catalase, superoxide dismutase (SOD) were pur-
chased from Sigma-Aldrich Chemicals Pvt. Ltd., Bangalore.
Serum and hepatic glucose levels were measured using
commercial kits from Sigma-Aldrich (Munich, Germany).
BCA protein kit was procured from Thermo Fisher Scien-
tific Inc., MA, USA. All other chemicals and reagents used
in this study were of analytical grade.
Plant material
Fresh leaves of P. graveolens at flowering stage were col-
lected in March 2008 in Sfax, South-East of Tunisia
(34° 47′ 57.0400 N, 10° 45′ 57.8900 E, Altitude 20 m),
which is characterized by its arid climate having a mean
rainfall of 200 mm per year. The leaves were manually
separated and dried in the shade. Then the botanical
identification of P. graveolens was conducted by Profes-
sor Makki Boukhris, botanist in the Faculty of Science
of Sfax, Tunisia. Voucher specimens were deposited at
the laboratory of Environmental bioprocesses (PG 22),
in the Centre of Biotechnology of Sfax.
Essential oil isolation
Fresh leaves of P. graveolens (600 g) were separately
grounded and submitted to hydrodistillation for 4 h
using a clevenger-type apparatus and the obtained oil
was dried over anhydrous sodium sulfate. The essential
oil from leaves has a yield of 0.19% on a dry basis.
Gas chromatography/mass spectrometry (GC/MS) analysis
The gas chromatography/mass spectrometry (GC/MS)
analysis of the essential oil was performed using Agilent
6890 N Network gas chromatographic (GC) system
equipped with a flame ionization detector. In fact, an ali-
quot of 1 μl of the essential oil was injected splitlessly
into the GC/MS. The samples were diffused in a 30
m-long 0.25 mm i.d. and 0.25 μm-thick DB-5MS column
(Agilent Technologies, J&W Scientific Products, USA)
and the carrier gas used was helium. The GC oven
temperature started at 100 °C and held for 1 min at
260 °C and then for 10 min with 4 °C min−1 programrate. While the injector and detector temperatures were
set at 250 and 230 °C, respectively, the mass range was
scanned from 50 to 550 amu. As for the control of the
GC/MS system and the data peak processing, they were
conducted by means of MSDCHEM software. With re-
gard to the identification of components, it was realized
via the comparison of the retention indices (RI) pertain-
ing to C9–C26 n-alkanes and MS corresponding data-
base (Wiley and NIST library) with the mass spectral
literature.
Animals
Male Wistar rats with body weights of 220 ± 10 g,
were purchased from the Central Pharmacy (SIPHAT,
Tunisia). They were fed on a pellet diet (SICO, Sfax,
Tunisia) and water ad libitum. They were also main-
tained in a controlled environment under standard condi-
tions of temperature and humidity with an alternating
light-and-dark cycle (12 h day/12 h night). According to
the European convention for the protection of vertebrate
animals used for experimental and other scientific pur-
poses (Council of Europe No 123, Strasbourg, 1985) and
the ethics committee for research on laboratory animal
use of our institution, rats rearing and experiments of this
study were approved.
Experimental induction of diabetes and treatments
The method of diabetes induction in rats by alloxan was
the same as described by Ananthan et al. [14]. Actually,
rats were single injected intraperitoneally with a freshly
prepared solution of alloxan monohydrate in normal sa-
line at a dose of 150 mg/kg b.w., freshly dissolved in
NaCl 0.9% buffer (pH 7). Since alloxan is capable of pro-
ducing fatal hypoglycemia because of massive pancreatic
insulin release, rats were orally treated with 20% glucose
solution 6 h after the injections. The rats were then kept
for the next 24 h on 5% glucose solution bottles in their
cages to prevent hypoglycemia. After 2 weeks, rats with
blood glucose level of above (10 mmol /dm3) were con-
sidered to be diabetic and used for the studies. The rats
were randomly divided into five experimental groups
(n = 8). Group 1 (C): normal rats. Group 2 (D): diabetic
rats (glycemia was more than 10 mmol /dm3). Groups 3:
diabetic rats treated with Glibenclamide (600 μg/kg.b.w.).
Groups 4–5 (EO1 and EO2): diabetic rats orally receiving
daily leaf essential oil of P. graveolens at 75 mg/ kg and
150 mg/kg respectively.
After one month of treatment, the animals were sacri-
ficed by decapitation, and the trunk blood was collected.
Then, the serum was prepared by centrifugation
(1500 × g, 15 min, 4 °C). Next, the kidneys and liver were
removed, cleaned of fat and stored at −80 °C until future
use. Immediately, pieces of liver and kidney were fixed
in a Bouin solution for histological studies.
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The activity of superoxide dismutase was examined by
the spectrophotometric method of Marklund and Mark-
lund [31]. Concerning the catalase (CAT), it was assayed
colorimetrically at 240 nm and expressed as moles of
H2O2 consumed per minute per milligram of protein, as
described by Regoli and Principato [32]. As for the gluta-
thione peroxidise (GPX) activity, it was measured by the
method described by Pagila and Valentine [33]. With re-
gard to the lipid peroxidation in the liver and kidneys of
control and all treated groups, it was measured by the
quantification of thiobarbituric acid-reactive substances
(TBARS) determined by the method of Park et al. [34].
Regarding the level of total protein, it was determined
referring to Lowry et al. [35] using bovine serum albu-
min as the standard at 660 nm. Furthermore, serum and
hepatic glucose levels were measured using commercial
kits from Sigma Munich (Munich, Germany). The Fast-
ing blood glucose was estimated by commercially avail-
able glucose strips (Accu-Chek Active) using One Touch
Glucometer (Johnson-Johnson). For histological studies,
pieces of liver and kidney were fixed in a Bouin solution
for 24 h, and then embedded in paraffin. 5 μm-thick sec-
tions were stained with hematoxylin-eosin and examined
under the Olympus DP-70 light microscope.
Statistical analysis
All data are presented as the mean ± SE values. The data
were evaluated by a one-way analysis of variance using
SPSS (Chicago, IL) software and differences between the
means were determined using Student’s t-test. Values
were considered statistically significant when p< 0.05.
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